The effect of vitrectomy on changes in molecular biomarker levels of the vitreous cavity in the early postoperative period in proliferative diabetic retinopathy

Determining the levels of molecular biomarkers detected in the vitreous body in various pathological conditions (including diabetic retinopathy), allows for a better understanding of their pathogenesis and optimization of treatment approaches. The multiplex assay is a modern alternative to enzyme-li...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vestnik oftal'mologii Ročník 141; číslo 2; s. 30
Hlavní autoři: Yusef, Yu, Petrachkov, D V, Baryshev, K V, Matyushchenko, A G
Médium: Journal Article
Jazyk:ruština
Vydáno: Russia (Federation) 2025
Témata:
ISSN:0042-465X
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Determining the levels of molecular biomarkers detected in the vitreous body in various pathological conditions (including diabetic retinopathy), allows for a better understanding of their pathogenesis and optimization of treatment approaches. The multiplex assay is a modern alternative to enzyme-linked immunosorbent assay (ELISA), enabling the simultaneous analysis of a large number of biomarkers. This study was performed to identify changes in the levels of vitreous biomarkers in patients with proliferative diabetic retinopathy (PDR) in the early postoperative period following 25-gauge vitrectomy. The study included 24 patients (24 eyes) with type 2 diabetes mellitus complicated by PDR requiring surgical intervention for tractional retinal detachment, subtotal or total vitreous hemorrhage, or tractional diabetic macular edema (DME). Vitreous samples were collected from all patients at the first stage of vitrectomy and one month after surgery. One month after surgery, the level of the pro-inflammatory cytokine vascular endothelial growth factor (VEGF) decreased from 203.8±228.0 to 113±95 pg/ml; however, the difference was not statistically significant ( =0.307). A significant reduction was observed in the concentrations of the following pro-inflammatory biomarkers: bFGF, CTACK, Eotaxin, HGF, IL-1β, -1α, -4, -12 (p40), -16, -18, IL-2Rα, IP-10, MIG, SCF, SCGF-β, SDF-1α, MIF, and M-CSF. The main effect of vitrectomy on pro-inflammatory cytokines is reduction of their concentration, which confirms the buffering role of the vitreous body in the accumulation of molecular biomarkers in diabetic retinopathy.
AbstractList Determining the levels of molecular biomarkers detected in the vitreous body in various pathological conditions (including diabetic retinopathy), allows for a better understanding of their pathogenesis and optimization of treatment approaches. The multiplex assay is a modern alternative to enzyme-linked immunosorbent assay (ELISA), enabling the simultaneous analysis of a large number of biomarkers. This study was performed to identify changes in the levels of vitreous biomarkers in patients with proliferative diabetic retinopathy (PDR) in the early postoperative period following 25-gauge vitrectomy. The study included 24 patients (24 eyes) with type 2 diabetes mellitus complicated by PDR requiring surgical intervention for tractional retinal detachment, subtotal or total vitreous hemorrhage, or tractional diabetic macular edema (DME). Vitreous samples were collected from all patients at the first stage of vitrectomy and one month after surgery. One month after surgery, the level of the pro-inflammatory cytokine vascular endothelial growth factor (VEGF) decreased from 203.8±228.0 to 113±95 pg/ml; however, the difference was not statistically significant ( =0.307). A significant reduction was observed in the concentrations of the following pro-inflammatory biomarkers: bFGF, CTACK, Eotaxin, HGF, IL-1β, -1α, -4, -12 (p40), -16, -18, IL-2Rα, IP-10, MIG, SCF, SCGF-β, SDF-1α, MIF, and M-CSF. The main effect of vitrectomy on pro-inflammatory cytokines is reduction of their concentration, which confirms the buffering role of the vitreous body in the accumulation of molecular biomarkers in diabetic retinopathy.
Determining the levels of molecular biomarkers detected in the vitreous body in various pathological conditions (including diabetic retinopathy), allows for a better understanding of their pathogenesis and optimization of treatment approaches. The multiplex assay is a modern alternative to enzyme-linked immunosorbent assay (ELISA), enabling the simultaneous analysis of a large number of biomarkers.Determining the levels of molecular biomarkers detected in the vitreous body in various pathological conditions (including diabetic retinopathy), allows for a better understanding of their pathogenesis and optimization of treatment approaches. The multiplex assay is a modern alternative to enzyme-linked immunosorbent assay (ELISA), enabling the simultaneous analysis of a large number of biomarkers.This study was performed to identify changes in the levels of vitreous biomarkers in patients with proliferative diabetic retinopathy (PDR) in the early postoperative period following 25-gauge vitrectomy.PURPOSEThis study was performed to identify changes in the levels of vitreous biomarkers in patients with proliferative diabetic retinopathy (PDR) in the early postoperative period following 25-gauge vitrectomy.The study included 24 patients (24 eyes) with type 2 diabetes mellitus complicated by PDR requiring surgical intervention for tractional retinal detachment, subtotal or total vitreous hemorrhage, or tractional diabetic macular edema (DME). Vitreous samples were collected from all patients at the first stage of vitrectomy and one month after surgery.MATERIAL AND METHODSThe study included 24 patients (24 eyes) with type 2 diabetes mellitus complicated by PDR requiring surgical intervention for tractional retinal detachment, subtotal or total vitreous hemorrhage, or tractional diabetic macular edema (DME). Vitreous samples were collected from all patients at the first stage of vitrectomy and one month after surgery.One month after surgery, the level of the pro-inflammatory cytokine vascular endothelial growth factor (VEGF) decreased from 203.8±228.0 to 113±95 pg/ml; however, the difference was not statistically significant (p=0.307). A significant reduction was observed in the concentrations of the following pro-inflammatory biomarkers: bFGF, CTACK, Eotaxin, HGF, IL-1β, -1α, -4, -12 (p40), -16, -18, IL-2Rα, IP-10, MIG, SCF, SCGF-β, SDF-1α, MIF, and M-CSF.RESULTSOne month after surgery, the level of the pro-inflammatory cytokine vascular endothelial growth factor (VEGF) decreased from 203.8±228.0 to 113±95 pg/ml; however, the difference was not statistically significant (p=0.307). A significant reduction was observed in the concentrations of the following pro-inflammatory biomarkers: bFGF, CTACK, Eotaxin, HGF, IL-1β, -1α, -4, -12 (p40), -16, -18, IL-2Rα, IP-10, MIG, SCF, SCGF-β, SDF-1α, MIF, and M-CSF.The main effect of vitrectomy on pro-inflammatory cytokines is reduction of their concentration, which confirms the buffering role of the vitreous body in the accumulation of molecular biomarkers in diabetic retinopathy.CONCLUSIONThe main effect of vitrectomy on pro-inflammatory cytokines is reduction of their concentration, which confirms the buffering role of the vitreous body in the accumulation of molecular biomarkers in diabetic retinopathy.
Author Matyushchenko, A G
Baryshev, K V
Yusef, Yu
Petrachkov, D V
Author_xml – sequence: 1
  givenname: Yu
  orcidid: 0000-0003-4043-456X
  surname: Yusef
  fullname: Yusef, Yu
  organization: I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
– sequence: 2
  givenname: D V
  orcidid: 0000-0003-4757-5584
  surname: Petrachkov
  fullname: Petrachkov, D V
  organization: Krasnov Research Institute of Eye Diseases, Moscow, Russia
– sequence: 3
  givenname: K V
  orcidid: 0000-0003-0927-430X
  surname: Baryshev
  fullname: Baryshev, K V
  organization: Krasnov Research Institute of Eye Diseases, Moscow, Russia
– sequence: 4
  givenname: A G
  orcidid: 0000-0002-0263-4096
  surname: Matyushchenko
  fullname: Matyushchenko, A G
  organization: Krasnov Research Institute of Eye Diseases, Moscow, Russia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40353538$$D View this record in MEDLINE/PubMed
BookMark eNo1UMlKBDEUzEFxXOYPRHL0Mpp0Z5k5iriB4EXB2_A6_eJE0502yQz03_ippl14kFdUqoqkjsheH3ok5JSzC645V5fBZvAdVKySXHBW8ZrtkUPGRLUQSr7OyDyld8YYF1JxrQ7ITLBallkekq_nDVK0Fk2mwdKdy7HA0I009NRsoH_DRF1Pu-DRbD1E2rjQQfzASD3u0KfJlkvIjzVsEzVQ4DiZJhoh-pEOIeUwYITsdkgLcKGdFEMM3tl_vnXQYHaGxnL2YYC8GU_IvgWfcP63j8nL7c3z9f3i8enu4frqcWG4rvNCawFGWmGFrBsmbSsaK1tegbSN1QokX6qV0dZwaHSj2KrwAkCbcmVgVVXH5Pw3tzzpc4sprzuXDHoP_fSrdV3qXaqaM1WkZ3_SbdNhux6iK42M6_9Wq2_9joFm
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.17116/oftalma202514102130
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
DocumentTitleAlternate Vliyanie vitrektomii na izmenenie soderzhaniya molekulyarnykh biomarkerov vitreal'noi polosti v rannem posleoperatsionnom periode pri proliferativnoi diabeticheskoi retinopatii
ExternalDocumentID 40353538
Genre English Abstract
Journal Article
GroupedDBID .GJ
53G
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
ECM
EIF
F5P
NPM
VCL
VIT
VME
7X8
ID FETCH-LOGICAL-c173t-774ac5f4f453b05fd4bf5d12a5fbf76a51869c7fc1ab7b6095fb4aa7c6a5ca922
IEDL.DBID 7X8
ISSN 0042-465X
IngestDate Mon May 12 17:11:29 EDT 2025
Tue May 13 01:31:58 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords molecular biomarkers
vitrectomy
diabetic retinopathy
multiplex assay
Language Russian
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c173t-774ac5f4f453b05fd4bf5d12a5fbf76a51869c7fc1ab7b6095fb4aa7c6a5ca922
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ORCID 0000-0003-4043-456X
0000-0003-4757-5584
0000-0003-0927-430X
0000-0002-0263-4096
PMID 40353538
PQID 3202863106
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3202863106
pubmed_primary_40353538
PublicationCentury 2000
PublicationDate 2025-00-00
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – year: 2025
  text: 2025-00-00
PublicationDecade 2020
PublicationPlace Russia (Federation)
PublicationPlace_xml – name: Russia (Federation)
PublicationTitle Vestnik oftal'mologii
PublicationTitleAlternate Vestn Oftalmol
PublicationYear 2025
SSID ssj0001456176
Score 2.2993515
Snippet Determining the levels of molecular biomarkers detected in the vitreous body in various pathological conditions (including diabetic retinopathy), allows for a...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 30
SubjectTerms Adult
Aged
Biomarkers - analysis
Biomarkers - metabolism
Diabetic Retinopathy - diagnosis
Diabetic Retinopathy - etiology
Diabetic Retinopathy - metabolism
Diabetic Retinopathy - surgery
Female
Follow-Up Studies
Humans
Male
Middle Aged
Postoperative Period
Treatment Outcome
Vascular Endothelial Growth Factor A - metabolism
Vitrectomy - adverse effects
Vitrectomy - methods
Vitreous Body - metabolism
Title The effect of vitrectomy on changes in molecular biomarker levels of the vitreous cavity in the early postoperative period in proliferative diabetic retinopathy
URI https://www.ncbi.nlm.nih.gov/pubmed/40353538
https://www.proquest.com/docview/3202863106
Volume 141
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF58Hbz4wFd9sYLX0G6yj_QkIooHLT0o9FZmNxkotElsasF_4091J5vSkyBIIIdNBrKbyeRjdub7GLs1WoIAsFGS9TGS1ojIxlpFmGtnwQmZB3b9FzMYpKNRf9gm3Oq2rHIVE5tAnZWOcuRd0vlOtQcj-q76iEg1inZXWwmNTbadeChDJV1mlK5zLIQOGn25pgtFajVqu-eMELrr4xxMZxATzJYkcZ30fseZzf_maf-_T3rA9lqkye-DaxyyjfnnEfv2bsFDDQcvkS8nC4p45eyLlwUPTcA1nxR8tlLN5dSfTyU8cz6l-qKazDxoDKblZ80dkPwEGdFwToTJvCK6jioPrOKcyJTLjO6oSCMIV-Mh7ztxnDopi5LEkb-O2fvT49vDc9SKNEROmGTh0bkEp1CiVIntKcykRZWJGBRaNBoUaV45g06ANZbo7dBKAOP8JQf9OD5hW0VZ5GeMa-qNA5SJRpAgFSSZX0eNLgNnjMAOu1kt-Nh_BLSzAQXNdLxe8g47DW9tXAW2jrHsJcof6fkfrC_YLnlDSLFcsm30ISC_YjtuuZjU8-vGu_x5MHz9ATVh38k
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+vitrectomy+on+changes+in+molecular+biomarker+levels+of+the+vitreous+cavity+in+the+early+postoperative+period+in+proliferative+diabetic+retinopathy&rft.jtitle=Vestnik+oftal%27mologii&rft.au=Yusef%2C+Yu&rft.au=Petrachkov%2C+D+V&rft.au=Baryshev%2C+K+V&rft.au=Matyushchenko%2C+A+G&rft.date=2025-01-01&rft.issn=0042-465X&rft.volume=141&rft.issue=2&rft.spage=30&rft_id=info:doi/10.17116%2Foftalma202514102130&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0042-465X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0042-465X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0042-465X&client=summon